Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Case report

Fatal Fournier’s gangrene caused by Clostridium ramosum in a patient with central diabetes insipidus and insulin-dependent diabetes mellitus: a case report

Authors: Noriyoshi Takano, Midori Sasaki Yatabe, Junichi Yatabe, Masaaki Kato, Daisuke Sueoka, Shigekazu Iguchi, Atsushi Yoshida, Yutaka Uzawa, Ken Kikuchi, Kimitaka Tani, Shinpei Ogawa, Michio Itabashi, Masakazu Yamamoto, Daisuke Watanabe, Takashi Ando, Satoshi Morimoto, Atsuhiro Ichihara

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Clostridium ramosum is a generally non-pathogenic enteric anaerobe, and Fournier’s gangrene is a rare necrotizing soft tissue infection with male predisposition affecting the perineum and the genital area. We report, to our knowledge, the first case of Fournier’s gangrene caused by C. ramosum in a female patient with multiple underlying conditions.

Case presentation

A 44-year-old woman with a 6-year history of insulin-dependent diabetes mellitus after total pancreatectomy and an 11-year history of central diabetes insipidus developed a pain in the genital area after a month of urinary catheter use. The lower abdominal pain worsened gradually over 2 weeks, and the pain, general fatigue, and loss of appetite prompted the patient’s hospital admission. As she had severe edema in her pelvic and bilateral femoral areas, ceftriaxone was started empirically after collecting two sets of blood cultures. On hospital day 2, CT examination revealed the presence of necrotizing faciitis in the genital and pelvic areas, and the antibiotics were changed to a combination of meropenem, vancomycin, and clindamycin. Gram-positive cocci and gram-positive rods were isolated from blood cultures, which were finally identified as Streptococcus constellatus and C. ramosum using superoxide dismutase and 16S rDNA sequencing. An emergent surgery was performed on hospital day 2 to remove the affected tissue. Despite undergoing debridement and receiving combined antimicrobial chemotherapies, the patient’s clinical improvement remained limited. The patient’s condition continued to deteriorate, and she eventually died on hospital day 8. In the present case, the underlying diabetes mellitus, urinary incontinence due to central diabetes insipidus, undernutrition, and edema served as the predisposing conditions.

Conclusions

C. ramosum is a potentially opportunistic pathogen among immunosuppressed persons and a rare cause of necrotizing fasciitis.
Literature
1.
go back to reference Yutin N, Galperin MY. A genomic update on clostridial phylogeny: gram-negative spore formers and other misplaced clostridia. Environ Microbiol. 2013;15(10):2631–41.PubMedPubMedCentral Yutin N, Galperin MY. A genomic update on clostridial phylogeny: gram-negative spore formers and other misplaced clostridia. Environ Microbiol. 2013;15(10):2631–41.PubMedPubMedCentral
2.
go back to reference Senda S, Fujiyama Y, Ushijima T, Hodohara K, Bamba T, Hosoda S, Kobayashi K. Clostridium ramosum, an IgA protease-producing species and its ecology in the human intestinal tract. Microbiol Immunol. 1985;29(11):1019–28.CrossRefPubMed Senda S, Fujiyama Y, Ushijima T, Hodohara K, Bamba T, Hosoda S, Kobayashi K. Clostridium ramosum, an IgA protease-producing species and its ecology in the human intestinal tract. Microbiol Immunol. 1985;29(11):1019–28.CrossRefPubMed
3.
go back to reference Leal J, Gregson DB, Ross T, Church DL, Laupland KB. Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000-2006. J Inf Secur. 2008;57(3):198–203. Leal J, Gregson DB, Ross T, Church DL, Laupland KB. Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000-2006. J Inf Secur. 2008;57(3):198–203.
4.
go back to reference Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N, Baspinar I. Fournier's gangrene: risk factors and strategies for management. World J Surg. 2006;30(9):1750–4.CrossRefPubMed Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N, Baspinar I. Fournier's gangrene: risk factors and strategies for management. World J Surg. 2006;30(9):1750–4.CrossRefPubMed
5.
go back to reference Bjurlin MA, O'Grady T, Kim DY, Divakaruni N, Drago A, Blumetti J, Hollowell CM. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology. 2013;81(4):752–8.CrossRefPubMed Bjurlin MA, O'Grady T, Kim DY, Divakaruni N, Drago A, Blumetti J, Hollowell CM. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology. 2013;81(4):752–8.CrossRefPubMed
6.
go back to reference van der Vorm ER, von Rosenstiel IA, Spanjaard L, Dankert J. Gas gangrene in an immunocompromised girl due to a Clostridium ramosum infection. Clin Infect Dis. 1999;28(4):923–4.CrossRefPubMed van der Vorm ER, von Rosenstiel IA, Spanjaard L, Dankert J. Gas gangrene in an immunocompromised girl due to a Clostridium ramosum infection. Clin Infect Dis. 1999;28(4):923–4.CrossRefPubMed
7.
go back to reference Kikuchi K, Matsuda M, Iguchi S, Mizutani T, Hiramatsu K, Tega-Ishii M, Sansaka K, Negishi K, Shimada K, Umemura J, et al. Potential impact of rapid blood culture testing for gram-positive bacteremia in Japan with the Verigene gram-positive blood culture test. Can J Infect Dis Med Microbiol. 2017;2017:4896791.PubMedPubMedCentralCrossRef Kikuchi K, Matsuda M, Iguchi S, Mizutani T, Hiramatsu K, Tega-Ishii M, Sansaka K, Negishi K, Shimada K, Umemura J, et al. Potential impact of rapid blood culture testing for gram-positive bacteremia in Japan with the Verigene gram-positive blood culture test. Can J Infect Dis Med Microbiol. 2017;2017:4896791.PubMedPubMedCentralCrossRef
8.
go back to reference Rennie RP, Turnbull L, Brosnikoff C, Cloke J. First comprehensive evaluation of the M.I.C. evaluator device compared to Etest and CLSI reference dilution methods for antimicrobial susceptibility testing of clinical strains of anaerobes and other fastidious bacterial species. J Clin Microbiol. 2012;50(4):1153–7.CrossRefPubMedPubMedCentral Rennie RP, Turnbull L, Brosnikoff C, Cloke J. First comprehensive evaluation of the M.I.C. evaluator device compared to Etest and CLSI reference dilution methods for antimicrobial susceptibility testing of clinical strains of anaerobes and other fastidious bacterial species. J Clin Microbiol. 2012;50(4):1153–7.CrossRefPubMedPubMedCentral
9.
go back to reference M100. Performance Standards for Antimicrobial Susceptibility Testing, 28th Edition. Clinical and Laboratory Standards Institute. 2018. ISBN Number: 1-56238-838-X. M100. Performance Standards for Antimicrobial Susceptibility Testing, 28th Edition. Clinical and Laboratory Standards Institute. 2018. ISBN Number: 1-56238-838-X.
10.
go back to reference M11. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 8th Edition. Clinical and Laboratory Standards Institute. 2012. ISBN Number: 1-56238-789-8. M11. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 8th Edition. Clinical and Laboratory Standards Institute. 2012. ISBN Number: 1-56238-789-8.
11.
go back to reference Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack CD, Wessells H. Fournier’s gangrene: population based epidemiology and outcomes. J Urol. 2009;181(5):2120–6.CrossRefPubMedPubMedCentral Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack CD, Wessells H. Fournier’s gangrene: population based epidemiology and outcomes. J Urol. 2009;181(5):2120–6.CrossRefPubMedPubMedCentral
12.
go back to reference Tenorio CEL, Lima SVC, Albuquerque AV, Cavalcanti MP, Teles F. Risk factors for mortality in Fournier’s gangrene in a general hospital: use of simplified founier gangrene severe index score (SFGSI). Int Braz J Urol. 2018;44(1):95–101.CrossRefPubMedPubMedCentral Tenorio CEL, Lima SVC, Albuquerque AV, Cavalcanti MP, Teles F. Risk factors for mortality in Fournier’s gangrene in a general hospital: use of simplified founier gangrene severe index score (SFGSI). Int Braz J Urol. 2018;44(1):95–101.CrossRefPubMedPubMedCentral
13.
go back to reference Furr J, Watts T, Street R, Cross B, Slobodov G, Patel S. Contemporary trends in the inpatient management of Fournier’s gangrene: predictors of length of stay and mortality based on population-based sample. Urology. 2017;102:79–84.CrossRefPubMed Furr J, Watts T, Street R, Cross B, Slobodov G, Patel S. Contemporary trends in the inpatient management of Fournier’s gangrene: predictors of length of stay and mortality based on population-based sample. Urology. 2017;102:79–84.CrossRefPubMed
14.
go back to reference Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier’s gangrene. J Urol. 1995;154(1):89–92.CrossRefPubMed Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier’s gangrene. J Urol. 1995;154(1):89–92.CrossRefPubMed
15.
go back to reference Yilmazlar T, Ozturk E, Ozguc H, Ercan I, Vuruskan H, Oktay B. Fournier’s gangrene: an analysis of 80 patients and a novel scoring system. Tech Coloproctol. 2010;14(3):217–23.CrossRefPubMed Yilmazlar T, Ozturk E, Ozguc H, Ercan I, Vuruskan H, Oktay B. Fournier’s gangrene: an analysis of 80 patients and a novel scoring system. Tech Coloproctol. 2010;14(3):217–23.CrossRefPubMed
16.
go back to reference Forrester JD, Spain DA. Clostridium ramosum bacteremia: case report and literature review. Surg Infect. 2014;15(3):343–6.CrossRef Forrester JD, Spain DA. Clostridium ramosum bacteremia: case report and literature review. Surg Infect. 2014;15(3):343–6.CrossRef
17.
go back to reference Alexander CJ, Citron DM, Brazier JS, Goldstein EJ. Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens. J Clin Microbiol. 1995;33(12):3209–15.PubMedPubMedCentral Alexander CJ, Citron DM, Brazier JS, Goldstein EJ. Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens. J Clin Microbiol. 1995;33(12):3209–15.PubMedPubMedCentral
18.
go back to reference Kosowska K, Reinholdt J, Rasmussen LK, Sabat A, Potempa J, Kilian M, Poulsen K. The Clostridium ramosum IgA proteinase represents a novel type of metalloendopeptidase. J Biol Chem. 2002;277(14):11987–94.CrossRefPubMed Kosowska K, Reinholdt J, Rasmussen LK, Sabat A, Potempa J, Kilian M, Poulsen K. The Clostridium ramosum IgA proteinase represents a novel type of metalloendopeptidase. J Biol Chem. 2002;277(14):11987–94.CrossRefPubMed
19.
go back to reference Van der Auwera P. Clinical significance of Streptococcus milleri. Eur J Clin Microbiol. 1985;4(4):386–90.CrossRefPubMed Van der Auwera P. Clinical significance of Streptococcus milleri. Eur J Clin Microbiol. 1985;4(4):386–90.CrossRefPubMed
20.
go back to reference Shinzato T, Saito A. A mechanism of pathogenicity of “Streptococcus milleri group” in pulmonary infection: synergy with an anaerobe. J Med Microbiol. 1994;40(2):118–23.CrossRefPubMed Shinzato T, Saito A. A mechanism of pathogenicity of “Streptococcus milleri group” in pulmonary infection: synergy with an anaerobe. J Med Microbiol. 1994;40(2):118–23.CrossRefPubMed
21.
go back to reference Nagashima H, Takao A, Maeda N. Abscess forming ability of Streptococcus milleri group: synergistic effect with Fusobacterium nucleatum. Microbiol Immunol. 1999;43(3):207–16.CrossRefPubMed Nagashima H, Takao A, Maeda N. Abscess forming ability of Streptococcus milleri group: synergistic effect with Fusobacterium nucleatum. Microbiol Immunol. 1999;43(3):207–16.CrossRefPubMed
Metadata
Title
Fatal Fournier’s gangrene caused by Clostridium ramosum in a patient with central diabetes insipidus and insulin-dependent diabetes mellitus: a case report
Authors
Noriyoshi Takano
Midori Sasaki Yatabe
Junichi Yatabe
Masaaki Kato
Daisuke Sueoka
Shigekazu Iguchi
Atsushi Yoshida
Yutaka Uzawa
Ken Kikuchi
Kimitaka Tani
Shinpei Ogawa
Michio Itabashi
Masakazu Yamamoto
Daisuke Watanabe
Takashi Ando
Satoshi Morimoto
Atsuhiro Ichihara
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3280-9

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue